Dr. Carl Lester Singerman - NPI #1134128556

Hematologist & Oncologist located in Northridge, CA

California Northridge Hematology & Oncology Dr. Carl Lester Singerman Information


Dr. Carl Lester Singerman is a male Hematologist & Oncologist (taxonomy code 207RH0003X) located in Northridge, California. Dr. Carl Lester Singerman's NPI Number is #1134128556 and has been listed in the NPI registry for 11 years. Dr. Carl Lester Singerman's practice location is listed as: 18300 Roscoe Blvd Northridge, CA 91325-4105 and can be reached via phone at (818) 700-2336.

Hematology & Oncology Taxonomy

The taxonomy code for Dr. Carl Lester Singerman's main specialty, Hematology & Oncology, is 207RH0003X. An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.



Be the first to rate Dr. Singerman

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1134128556
 Phone (818) 700-2336
 Fax (818) 700-2337
18300 Roscoe Blvd
Northridge, CA 91325-4105
 Gender M
 Website Not provided
  • Hematology & Oncology (CA)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 6/8/2011
 Added 7/18/2005
 Viewed on 10/25/2016
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.